Pioneering solutions, saving lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
| Brain Tumour / Neurosurgery: | NsurgClerk@mh.org.au |
| Dementia: | DementiaTrials@mh.org.au |
| Epilepsy: | EpilepsyCoordinator@mh.org.au |
| Huntington’s Disease: | RMHHuntingtonDiseaseStudies@mh.org.au |
| Movement Disorders: | PDNurse@mh.org.au |
| Multiple Sclerosis: | MSClinic@mh.org.au |
| Neurophysiology: | RMH-ClinicalNeurophysiology@mh.org.au |
| Stroke: | RMH-StrokeResearchTeam@mh.org.au |
| General: | Neuro.Foundation@mh.org.au |
Staged Workflow Assessment and Data Collection Study of the EMVision First Responder Brain Scanner in the Melbourne Mobile Stroke Unit
Treatment Of Stroke reCurrence in Cerebral Amyloid Angiopathy (CAA) with TraneXamic Acid (TOSCCAA-TXA)
LOw dose combinations To improve stroke oUtcomeS (LOTUS)
A multi-faCtorial, mulTi-arm, multi-staGe, randomised, gLOBal pLatform trial for Stroke (ACT-GLOBAL)
A Double-Blind, Placebo-Controlled, Proof-of-Concept Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod on Recovery after Moderate to Severe Acute Ischaemic Stroke